New York, NY, United States of America

Albert Ruzo


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Overview of Inventor Albert Ruzo and His Contributions to Huntington's Disease Research

Introduction: Albert Ruzo is an innovative inventor based in New York, NY, known for his significant contributions to the field of biomedical research, particularly in relation to Huntington's Disease. He holds a patent concerning embryonic cell-based therapeutic candidate screening systems, which aims to advance our understanding and treatment of this debilitating condition.

Latest Patents: Albert Ruzo's noteworthy patent, titled "Embryonic cell-based therapeutic candidate screening systems, models for Huntington's Disease and uses thereof," revolves around the composition and methods involving isogenic human embryonic stem cells. These cells possess a disease form of the Huntingtin gene (HTT) at the endogenous locus within their genome. Specifically, the disease form includes a polyQ repeat of at least 40 glutamines at the N-terminus of the Huntingtin protein. The genetically-modified cell lines developed by Ruzo recapitulate the characteristics of Huntington's Disease, allowing for a deeper investigation into potential treatments. The inclusion of isogenic controls, which share a similar genetic background, enhances the reliability of these models in drug discovery.

Career Highlights: Ruzo is affiliated with The Rockefeller University, a leading institution known for its focus on scientific research and innovation. His work there underscores a commitment to advancing knowledge in the realms of genetics, cellular biology, and therapeutic development. The patent secured by Ruzo reflects his dedication to leveraging cutting-edge science to combat neurodegenerative diseases.

Collaborations: Throughout his career, Ruzo has collaborated with distinguished colleagues such as Ali Brivanlou and Alessia Deglincerti. Together, they create a synergistic environment that fosters innovative research and the exploration of novel therapeutic avenues for Huntington's Disease.

Conclusion: Albert Ruzo stands out as a pivotal figure in the study of Huntington's Disease, with his patented innovations significantly enabling drug discovery processes. His efforts at The Rockefeller University, along with his collaborative work, contribute to a greater understanding of this tragic condition and offer hope for future breakthroughs in treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…